bmt: Bone marrow transplantation data
In geecure: Marginal Proportional Hazards Mixture Cure Models with Generalized Estimating Equations
Description
Usage
Format
References
Description
This multi-center acute leukemia study consists of 137 patients with acute myelocytic leukemia (AML) or acute lymphoblastic leukemia (ALL) aged 7 to 52 from March 1, 1984 to June 30, 1989 at four institutions (Klein and Moeschberger, 2003). The failure time on study is defined at time (in days) to relapse or death.
Usage
1
Format
The variables represented in the data set are as follows:
gDisease group: 1 - All, 2 - AML Low Risk, 3 - AML High Risk.
T1Time to death or on study time.
T2Disease free survival time (time to relapse, death or end of study).
d1Death indicator: 1 - Dead, 0 - Alive.
d2Relapse indicator: 1 - Relapsed, 0 - Disease Free.
d3Disease free survival indicator: 1 - Dead or Relapsed, 0 - Alive Disease Free.
TATime to Acute Graft-Versus-Host Disease.
daAcute GVHD indicator: 1 - Developed Acute GVHD, 0 - Never Developed Acute GVHD.
TCTime to Chronic Graft-Versus-Host Disease.
dcChronic GVHD Indicator: 1 - Developed Chronic GVHD, 0 - Never Developed Chronic GVHD.
TPTime to return of platelets to normal levels.
dpPlatelet recovery indicator: 1 - platelets returned to normal, 0 - platelets never returned to normal.
Z1Patient age in years.
Z2Donor age in years.
Z3Patient sex: 1 - Male, 0 - Female.
Z4Doner sex: 1 - Male, 0 - Female.
Z5Patient CMV status: 1 - CMV positive, 0 - CMV negative.
Z6Donor CMV status: 1 - CMV positive, 0 - CMV negative.
Z7Waiting time to transplant in days.
Z8FAB: 1 - FAB Grade 4 or 5 and AML, 0 - otherwise.
Z9Hospital: 1 - The Ohio State University, 2 - Alferd , 3 - St. Vincent, 4 - Hahnemann.
Z10MTX: used as a Graft-Versus-Host-Prophylactic 1 - Yes, 0 - No.
References
Klein, J. P. and Moeschberger, M. L. (2003) Survival Analysis: Techniques for Censored and Truncated Data. Springer, New York, 2nd edition.
geecure documentation built on May 2, 2019, 6:03 a.m.
R Package Documentation
Browse R Packages
We want your feedback!
Note that we can't provide technical support on individual packages. You should contact the package authors for that.
Description Usage Format References
Description
This multi-center acute leukemia study consists of 137 patients with acute myelocytic leukemia (AML) or acute lymphoblastic leukemia (ALL) aged 7 to 52 from March 1, 1984 to June 30, 1989 at four institutions (Klein and Moeschberger, 2003). The failure time on study is defined at time (in days) to relapse or death.
Usage
1 |
Format
The variables represented in the data set are as follows:
gDisease group: 1 - All, 2 - AML Low Risk, 3 - AML High Risk.
T1Time to death or on study time.
T2Disease free survival time (time to relapse, death or end of study).
d1Death indicator: 1 - Dead, 0 - Alive.
d2Relapse indicator: 1 - Relapsed, 0 - Disease Free.
d3Disease free survival indicator: 1 - Dead or Relapsed, 0 - Alive Disease Free.
TATime to Acute Graft-Versus-Host Disease.
daAcute GVHD indicator: 1 - Developed Acute GVHD, 0 - Never Developed Acute GVHD.
TCTime to Chronic Graft-Versus-Host Disease.
dcChronic GVHD Indicator: 1 - Developed Chronic GVHD, 0 - Never Developed Chronic GVHD.
TPTime to return of platelets to normal levels.
dpPlatelet recovery indicator: 1 - platelets returned to normal, 0 - platelets never returned to normal.
Z1Patient age in years.
Z2Donor age in years.
Z3Patient sex: 1 - Male, 0 - Female.
Z4Doner sex: 1 - Male, 0 - Female.
Z5Patient CMV status: 1 - CMV positive, 0 - CMV negative.
Z6Donor CMV status: 1 - CMV positive, 0 - CMV negative.
Z7Waiting time to transplant in days.
Z8FAB: 1 - FAB Grade 4 or 5 and AML, 0 - otherwise.
Z9Hospital: 1 - The Ohio State University, 2 - Alferd , 3 - St. Vincent, 4 - Hahnemann.
Z10MTX: used as a Graft-Versus-Host-Prophylactic 1 - Yes, 0 - No.
References
Klein, J. P. and Moeschberger, M. L. (2003) Survival Analysis: Techniques for Censored and Truncated Data. Springer, New York, 2nd edition.
R Package Documentation
Browse R Packages
We want your feedback!
Note that we can't provide technical support on individual packages. You should contact the package authors for that.
Embedding an R snippet on your website
Add the following code to your website.
For more information on customizing the embed code, read Embedding Snippets.